Department of Pathology, Central Electron Microscopy Facility, Wellcome Trust Research Laboratory, Christian Medical College, Vellore, Tamil Nadu, India.
Department of Nephrology, Christian Medical College, Vellore, Tamil Nadu, India.
Indian J Pathol Microbiol. 2020 Jul-Sep;63(3):463-466. doi: 10.4103/IJPM.IJPM_756_18.
The renal diseases commonly associated with myeloma include primary amyloidosis, cast nephropathy, and light chain deposition disease. Less frequent forms of renal involvement encountered in the course of myeloma are crystalline and non-crystalline proximal tubulopathies, neoplastic plasma cell infiltration, and immunoglobulin crystallization in interstitial histiocytes and glomerular cells including podocytes. Light chain proximal tubulopathy (LCPT) caused by aggregation of non-crystalline and rarely crystalline deposits of monoclonal light chains in the cytoplasm of proximal tubular epithelial cells, accounts for less than 5% of monoclonal gammopathy-associated kidney diseases. We report the case of a 48-year-old Indian woman with multiple myeloma, who presented with acute kidney injury and nephrotic syndrome, in whom the renal biopsy revealed widespread crystalline inclusions in extraglomerular and glomerular compartments. We present illustrative light microscopic (LM) and diagnostic electron microscopic (EM) findings of this case which enabled a diagnosis of crystalline LCPT, crystal storing histiocytosis, and crystalline podocytopathy occurring synchronously with myeloma cast nephropathy. While documenting this unique juxtapositioning of multicompartmental paraproteinemic renal injury in multiple myeloma, diagnosed after EM analysis of the patient's renal biopsy, we discuss the pathogenetic pathways of this condition along with the clinical implications. Due to intrinsic structural properties of the crystals, they frequently escape detection by routine LM, necessitating EM analysis for their diagnosis. Given the prognostic implications of tubulopathies complicating myeloma, LCPT is a critically important diagnosis, highlighting the need for a comprehensive renal biopsy evaluation inclusive of EM for the practice of precision medicine in such scenarios.
与骨髓瘤相关的肾脏疾病包括原发性淀粉样变性、铸型肾病和轻链沉积病。在骨髓瘤的病程中,较少见的肾脏受累形式包括结晶和非结晶近端肾小管病变、肿瘤浆细胞浸润以及间质组织细胞和包括足细胞在内的肾小球细胞中的免疫球蛋白结晶。由单克隆轻链的非结晶和罕见结晶沉积物在近端肾小管上皮细胞细胞质中的聚集引起的轻链近端肾小管病(LCPT),占单克隆丙种球蛋白相关性肾脏病的不到 5%。我们报告了一例 48 岁的印度女性患有多发性骨髓瘤,她表现为急性肾损伤和肾病综合征,肾活检显示广泛的肾小球外和肾小球内结晶包涵体。我们展示了这个病例的有代表性的光镜(LM)和诊断电子显微镜(EM)发现,这些发现使我们能够诊断为结晶 LCPT、晶体储存组织细胞病和结晶性足细胞病,这些疾病与骨髓瘤铸型肾病同时发生。在记录多发性骨髓瘤中多部位副蛋白血症性肾损伤的这种独特并置情况时,我们在对患者的肾活检进行 EM 分析后诊断出这种情况,并讨论了这种疾病的发病机制途径及其临床意义。由于晶体的固有结构特性,它们经常逃避常规 LM 的检测,需要进行 EM 分析以进行诊断。鉴于骨髓瘤合并的肾小管病的预后意义,LCPT 是一个非常重要的诊断,强调在这种情况下需要进行全面的肾脏活检评估,包括 EM,以进行精准医学实践。